Islet cell function in type 1 and type 2 diabetes

被引:0
|
作者
Hao, W [1 ]
Palmer, JP [1 ]
机构
[1] Dept Vet Affairs, Puget Sound Hlth Care Syst, Seattle, WA 98108 USA
来源
JOURNAL OF CLINICAL LIGAND ASSAY | 1998年 / 21卷 / 03期
关键词
diabetes; insulin; C-peptide; glucose; arginine; glucagon; insulin sensitivity; beta cell function; insulin secretion;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The primary hormone controlling glucose metabolism is insulin. A deficiency in insulin secretion is a central defect in the pathophysiology of both type 1 and type 2 diabetes. In this review we discuss the abnormalities of insulin secretion characteristic of both forms of diabetes. We describe most of the commonly employed tests of beta cell function and explore their relative advantages and disadvantages. Usually, there is a trade-off between the complexity of the test and the amount of information obtained. For example, measuring insulin or C-peptide during the fasting state provides far less information on total beta cell functional capacity than does dynamic beta cell testing at different glucose levels using several intravenous beta cell secretagogues. Since insulin and C-peptide are the primary measurements used during beta cell testing, a few caveats are provided regarding both of these assays and the interpretation of results.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 50 条
  • [1] β-cell function following human islet transplantation for type 1 diabetes
    Rickels, MR
    Schutta, MH
    Markmann, JF
    Barker, CF
    Naji, A
    Teff, KL
    DIABETES, 2005, 54 (01) : 100 - 106
  • [2] Monoamines' role in islet cell function and type 2 diabetes risk
    Roberts, Fiona Louise
    Cataldo, Luis Rodrigo
    Fex, Malin
    TRENDS IN MOLECULAR MEDICINE, 2023, 29 (12) : 1045 - 1058
  • [3] Islet cell transplantation for Type 1 diabetes
    Matsumoto, Shinichi
    JOURNAL OF DIABETES, 2010, 2 (01) : 16 - 22
  • [4] Islet cell autoantigens in type 1 diabetes
    Christie, MR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (10) : 827 - 838
  • [5] Islet β cell failure in type 2 diabetes
    Prentki, Marc
    Nolan, Christopher J.
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07): : 1802 - 1812
  • [6] Effect of exenatide on β cell function after islet transplantation in type 1 diabetes
    Al Ghofaili, Khalid
    Fung, Michelle
    Ao, Ziliang
    Meloche, Mark
    Shapiro, R. Jean
    Warnock, Garth L.
    Elahi, Darlush
    Meneilly, Graydon S.
    Thompson, David M.
    TRANSPLANTATION, 2007, 83 (01) : 24 - 28
  • [7] Genomics of Islet (Dys)function and Type 2 Diabetes
    Lawlor, Nathan
    Khetan, Shubham
    Ucar, Duygu
    Stitzel, Michael L.
    TRENDS IN GENETICS, 2017, 33 (04) : 244 - 255
  • [8] Impact of treatment on islet function in type 2 diabetes
    Henquin, JC
    Boitard, C
    Cerasi, E
    Ferrannini, E
    Steiner, DF
    Efendic, S
    DIABETES, 2004, 53 : S1 - S5
  • [9] Inflammatory mediators and islet β-cell failure:: a link between type 1 and type 2 diabetes
    Donath, MY
    Storling, J
    Maedler, K
    Mandrup-Poulsen, T
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (08): : 455 - 470
  • [10] Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes
    Marc Y. Donath
    Joachim Størling
    Kathrin Maedler
    Thomas Mandrup-Poulsen
    Journal of Molecular Medicine, 2003, 81 : 455 - 470